LabCompass

Tadanobu Utsuki

Medicine · Purdue University West Lafayette

Established · publishing since 1991

Publications

37

Citations

3,152

Est. group size

Recurring co-author estimate

Active years

34

Publishing since 1991

Research summary
AI-generated

Tadanobu Utsuki's work spans neurodegenerative disease research (particularly Alzheimer's disease and drug candidates like Posiphen), anti-inflammatory effects of natural compounds derived from seaweed and other plants, and drug delivery systems using materials like polylactic acid. Much of this research investigates how bioactive compounds from natural sources (algae, avocado) can reduce inflammation in brain cells or protect against diet-related health problems, often using cell culture and animal models. This work sits at the intersection of pharmacology, nutrition science, and neuroscience.

Alzheimer's disease and neurodegenerationNatural bioactive compounds (seaweed, plant extracts)Anti-inflammatory mechanisms in microglial and immune cellsDrug delivery systems and pharmacokineticsDiet and metabolic health

Publication output has been low and irregular over the last decade, generally producing zero to two papers per year with an average of less than one publication annually in the most recent five years.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026

Publication cadence
Publications per year over the last 10 years — averaging 0.6/year recently
172018: 2 publications218192020: 1 publication202021: 1 publication212022: 1 publication222023: 1 publication232024: 1 publication242526
Publishes in
  • PLoS ONE×2
  • Advanced Drug Delivery Reviews×1
  • Alzheimer s & Dementia Translational Research & Clinical Interventions×1
  • Immunopharmacology and Immunotoxicology×1
  • International Immunopharmacology×1
Similar researchers
By research-topic overlap

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 20, 2026.

Claim or correct this profile